ITGR
HealthcareInteger Holdings Corporation · Medical - Devices · $3B
What is Integer Holdings Corporation?
Integer Holdings Corporation is a contract manufacturer of medical devices serving some of the world's largest healthcare companies. Headquartered in Plano, Texas, it operates across the United States, Puerto Rico, Costa Rica, and international markets.
Integer Holdings manufactures components and finished devices for medical OEMs under a contract manufacturing model, meaning it earns revenue by producing products designed by its customers rather than selling its own branded devices. Its two segments — Medical and Non-Medical — cover a wide range of implantable devices, surgical tools, and specialized battery systems. Revenue depends heavily on long-term supply agreements with large medical device companies, making customer concentration and contract renewals central to its business model.
Integer Holdings was established in 2000 and is headquartered in Plano, Texas.
- Cardiac rhythm management devices including pacemakers and defibrillators
- Neuromodulation products such as implantable spinal cord stimulators
- Interventional cardiology and vascular procedure components
- Surgical instruments for orthopedic, laparoscopic, and arthroscopic procedures
- Customized battery and power management systems for implantable devices
Is ITGR a Good Stock to Buy?
UQS Score rates ITGR as Below Average overall.
Among the five pillars, Valuation stands out as the relative bright spot, suggesting the stock is not trading at a significant premium relative to its fundamentals. Risk registers as Neutral, indicating the company does not carry an outsized threat profile compared to peers in the healthcare manufacturing space.
Quality, Moat, and Growth all register as Weak — a combination that signals limited competitive differentiation, constrained earnings quality, and little evidence of near-term expansion momentum.
See the exact pillar breakdown and full financial metrics by signing up for a UQS Pro account. Sign up free →
Past performance does not guarantee future results. UQS Score is based on fundamental data and is not a buy/sell recommendation.
Does ITGR pay dividends?
No — Integer Holdings Corporation does not currently pay a dividend.
Integer Holdings does not currently pay a dividend. As a contract manufacturer operating with meaningful debt from acquisitions, the company directs available capital toward debt reduction and operational investment rather than shareholder distributions. Income-focused investors should factor this into their assessment of ITGR.
When does ITGR report earnings?
Integer Holdings reports earnings on a quarterly cadence, consistent with standard practice for US-listed equities.
Revenue trends reflect the company's reliance on large OEM customers and the pace of procedure volumes in its end markets. Profitability has been pressured by input costs and integration expenses tied to prior acquisitions, themes that have defined recent reporting periods.
For the most recent quarter's results and guidance updates, visit Integer Holdings' investor relations page directly.
ITGR Price History
-5.4% over 5Y
Monthly close, adjusted for stock splits and dividend reinvestment.
What if I invested in Integer Holdings Corporation?
Based on Integer Holdings Corporation's historical closing prices, adjusted for stock splits and dividend reinvestment. Past performance does not guarantee future results. This is for informational purposes only and is not financial advice.
ITGR Long-term Outlook
The UQS Growth pillar for ITGR registers as Weak, suggesting the near-term fundamental trajectory does not point to accelerating expansion. The Neutral Risk profile provides some stability, but the combination of Weak Quality and Weak Moat limits confidence in durable margin improvement. Investors considering a longer horizon should weigh whether end-market procedure growth can offset the structural pressures visible in the current pillar profile.
Growth drivers
- Rising global demand for implantable cardiac and neuromodulation devices
- Long-term OEM supply agreements providing baseline revenue visibility
- Potential for margin recovery as acquisition-related costs normalize
Key risks
- Customer concentration risk from dependence on a small number of large OEMs
- Debt load from past acquisitions limiting financial flexibility
- Competitive pressure from other contract manufacturers and in-house OEM production
ITGR vs Peers
Integer Holdings competes in the broader medical device and outsourced manufacturing space alongside companies with distinct business models and end-market focuses.
LivaNova develops and sells its own branded cardiac and neuromodulation devices, operating as an OEM rather than a contract manufacturer like Integer.
TransMedics focuses on organ transplant logistics and perfusion technology, a narrower and higher-growth niche compared to Integer's broad contract manufacturing scope.
iRhythm is a digital health company centered on wearable cardiac monitoring, competing in cardiac diagnostics rather than device component manufacturing.
Frequently Asked Questions
What does Integer Holdings do?
Integer Holdings is a contract manufacturer that produces medical device components and finished products for large healthcare OEMs. Its output spans implantable cardiac devices, neuromodulation systems, surgical instruments, and specialized battery solutions. It also operates a smaller Non-Medical segment focused on customized power systems.
Does ITGR pay dividends?
ITGR does not currently pay a dividend. The company prioritizes debt management and reinvestment over shareholder distributions, which is common among contract manufacturers that have grown through acquisitions. Investors seeking income should look elsewhere in the healthcare sector.
When does ITGR report earnings?
Integer Holdings follows a standard quarterly earnings cadence for US-listed companies. Specific dates are not covered by our data source — check the company's investor relations page or a financial calendar for the most current schedule.
Is ITGR a good stock to buy?
UQS Score rates ITGR as Below Average, driven by Weak readings across Quality, Moat, and Growth pillars. The Valuation pillar is a relative positive, and Risk is Neutral. Whether that profile suits your portfolio depends on your investment criteria — the full pillar breakdown is available to Pro members.
Is ITGR overvalued?
The UQS Valuation pillar for ITGR rates as Good, suggesting the stock is not trading at an excessive premium relative to its fundamentals. However, valuation alone does not make a complete investment case — the Quality and Moat pillars are both Weak, which tempers the appeal of the current price level.
How does ITGR compare to its competitors?
Unlike LivaNova or iRhythm, which develop and sell branded medical devices, Integer operates as a contract manufacturer — its revenue depends on winning and retaining OEM supply contracts rather than end-patient demand for its own products. This model carries different margin dynamics and competitive risks than branded device companies.
What is ITGR's market cap bracket?
Integer Holdings is classified as a mid-cap company. This places it in a size range that typically offers more liquidity than small-cap peers but less analyst coverage and institutional attention than large-cap healthcare names.
Who founded Integer Holdings?
Integer Holdings was established in 2000. Detailed founding history, including executive leadership at inception, is publicly available through the company's official corporate history and SEC filings.
Is ITGR a long-term quality indicator?
From a UQS perspective, ITGR's long-term quality profile is constrained by Weak readings on Quality, Moat, and Growth pillars. A durable long-term holding typically benefits from a strong moat and consistent earnings quality — areas where ITGR currently scores below average. The Neutral Risk pillar offers some reassurance on downside exposure.
What is the main competitive advantage of Integer Holdings?
Integer's scale and breadth of manufacturing capabilities across multiple device categories give it relevance to large OEM customers seeking a single outsourced partner. However, the UQS Moat pillar rates as Weak, suggesting this advantage has not translated into durable pricing power or returns that clearly exceed peers.
What sector does ITGR belong to?
Integer Holdings operates in the Healthcare sector, specifically within medical device outsourced manufacturing. It serves customers across interventional cardiology, neuromodulation, surgical devices, and orthopedics — making it a broad-based supplier rather than a specialist in one therapeutic area.
Unlock Full ITGR Analysis
Sign in to unlock the detailed analysis behind the UQS Score.
- ✓View the exact UQS Score and all five pillar scores
- ✓Access full financial metrics and trend data
- ✓See how ITGR ranks within the Healthcare sector
- ✓Compare ITGR against peers on every quality dimension
- ✓Get the complete analyst-style breakdown in one view
Pro Analysis
ITGR — Score History
| Date | UQS | Quality | Moat | Growth | Risk | Value | Change |
|---|---|---|---|---|---|---|---|
| May 7, 2026 | 43.1 | 34.3 | 35.0 | 35.2 | 45.4 | 79.2 | -0.5 |
| May 4, 2026 | 43.6 | 35.5 | 35.0 | 35.1 | 45.4 | 80.9 | -0.5 |
| May 3, 2026 | 44.1 | 35.5 | 35.0 | 36.8 | 45.4 | 82.0 | +0.1 |
| Apr 26, 2026 | 44.0 | 35.5 | 35.0 | 36.8 | 45.4 | 81.1 | +0.4 |
| Apr 19, 2026 | 43.6 | 35.5 | 35.0 | 36.8 | 45.4 | 78.6 | -0.4 |
| Apr 18, 2026 | 44.0 | 35.8 | 35.0 | 36.8 | 45.4 | 80.6 | -0.2 |
| Apr 17, 2026 | 44.2 | 35.8 | 35.0 | 36.8 | 45.4 | 82.4 | +0.2 |
| Apr 16, 2026 | 44.0 | 35.5 | 35.0 | 36.8 | 45.4 | 81.6 | -0.5 |
| Apr 12, 2026 | 44.5 | 35.9 | 35.0 | 36.8 | 45.4 | 83.7 | +0.2 |
| Apr 11, 2026 | 44.3 | 35.9 | 35.0 | 36.8 | 45.4 | 82.7 | 0.0 |
ITGR — Pillar Breakdown
Quality
— 36.1/100 (25%)Integer Holdings Corporation has average quality metrics, with room for improvement in margins or capital efficiency.
How effectively capital is deployed to generate returns.
Profitability relative to shareholders' equity.
Ability to convert revenue into operating profit.
Bottom-line profit as a share of revenue.
Asset productivity — how much gross profit each dollar of assets generates.
Free cash flow relative to market value.
Growth
— 34.7/100 (20%)Integer Holdings Corporation faces growth headwinds with declining or stagnant revenue trends.
Revenue trajectory over the last twelve months.
Compound annual revenue growth rate over 3 years.
Year-over-year earnings per share growth.
Analyst consensus for future revenue growth.
Analyst consensus for future earnings growth.
Risk
— 45.1/100 (15%)Integer Holdings Corporation has some risk factors including moderate leverage or solvency concerns.
Debt levels relative to earnings capacity.
Total debt relative to shareholder equity.
Short-term liquidity — ability to pay near-term obligations.
Earnings capacity relative to interest payments.
Valuation
— 72.7/100 (15%)Integer Holdings Corporation trades at a reasonable valuation with decent earnings yield and FCF multiples.
Inverse of forward P/E — higher yield means cheaper stock.
How many years of FCF the market cap represents.
P/E relative to earnings growth — lower is more attractive.
Enterprise value multiple relative to sector median.
Moat
— 35/100 (25%)Integer Holdings Corporation possesses some competitive advantages but faces meaningful competition. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for ITGR.
Score Composition
Financial Data
More Stock Analysis
How is the ITGR UQS Score Calculated?
The UQS (Unified Quality Score) for Integer Holdings Corporation is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.
Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.
Moat (25%) assesses Integer Holdings Corporation's competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.
Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.
Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.
Valuation (15%) measures whether Integer Holdings Corporation is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.
Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.